natgillin/translations-raw huggingface dataset:
α-[4-(4-dimethylamino-α-4-[ethyl(3-sodiosulphonato benzyl)amino] phenylbenzylidene)cyclohexa-2,5-dienylidene(ethyl)ammonio]toluene-3-sulphonate
1; H317: C ≥ 0,1 %
Mineral wool, with the exception of those specified elsewhere in this Annex;
1,4,5,8-tetraaminoantrakinon;
≤ C < 1 %
2; H315: C ≥ 5 %
029-012-00-4 sodium ((N-(3-trimethylammoniopropyl)sulfamoyl)methylsulfonatophthalocyaninato)copper(II)
235-008-5 [1]
082-003-01-4 lead diazide;
10028-18-9 [1]
602-008-00-5 carbon tetrachloride;
252-840-4 [6]
1B; H314: C ≥25 % Skin Irrit.
13775-54-7 [2]
2; H319: 0,06 % ≤ C < 0,6 %
84852-37-9 [12]
648-126-00-0 Tar acids, cresylic, residues; Distillate Phenols;
234-495-1 [3]
649-017-00-0
235-723-2 [4]
649-019-00-1 Residues (petroleum), atmospheric;
235-033-1 [5]
Heavy Fuel oil; [A complex residuum from atmospheric distillation of crude oil.
235-379-3 [6]
Distillates (petroleum), light naphthenic; Unrefined or mildly refined baseoil;
12035-39-1 [2]
649-054-00-2 Distillates (petroleum), acid-treated heavy naphthenic; Unrefined or mildly refined baseoil;
52502-12-2 [4]
Gases (petroleum), depropanizer overheads; Petroleum gas;
7733-02-0 [2]
Hydrocarbons, C1-4, sweetened; Petroleum gas; [A complex combination of hydrocarbons obtaine by subjectin hydrocarbon gases to a sweetening process to convert mercaptans o to remove acidc impurities.
209-805-3 [1]
Gases (petroleum), alkylation feed; Petroleum gas;
202-866-7 [2]
Gases (petroleum), refinery blend; Petroleum gas;
55-68-5 [1]
[A complex combination obtained from various processes.
100-57-2 [2]
Gases (petroleum), catalytic cracking; Petroleum gas;
7487-94-7
It consists of hydrocarbons having a carbon number predominantly of C4.]
209-280-0 [5]
It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C4.]
209-730-6 [8]
K S U
464-06-2 [3]
Refinery gas; [The feed gas to the amine system for removal of hydrogen sulfide.
565-59-3 [5]
It consists of hydrogen.
589-34-4 [6]
Carbon monoxide and hydrocarbons having carbon numbers predominantly in the range of C1 through C6, including benzene, may also be present.]
203-892-1 [1]
from polymerization of naphtha.
560-21-4 [3]
649-264-00-4
592-27-8 [14]
mancozeb (ISO); manganese
138-86-3 [1]
234-323-5[2]-[3]
2437-29-8 [2]
240-841-2[1]
247-148-4 [1]
234-349-7[2]-[3]
209-512-0 [1]
234-829-6[1]
231-187-9 [2]
2; H319: 2 %≤
123-73-9 [2]
649-388-00-9
209-357-9 [3]
649-391-00-5
66-56-8 [1]
649-393-00-6
329-71-5 [2]
649-396-00-2
573-56-8 [3]
649-397-00-8
495-54-5
649-400-00-2
208-545-8 [1]
649-404-00-4
278-290-5 [2]
649-406-00-5
279-116-0 [3]
649-413-00-3
264-409-8 [4]
649-419-00-6
281-549-5 [5]
649-421-00-7
282-432-1 [6]
649-424-00-3
532-82-1 [1]
GHS08-Dgr
75660-25-2 [2]
649-427-00-X
79234-33-6 [3]
649-433-00-2
63681-54-9 [4]
649-435-00-3
83968-67-6 [5]
649-439-00-5
84196-22-5 [6]
649-453-00-1
286-946-7 [1]
649-462-00-0
304-236-8 [2]
649-468-00-3
85407-90-5 [1]
649-472-00-5
94247-67-3 [2]
649-475-00-1
200-820-0 [1]
649-477-00-2
204-697-4 [2]
649-480-00-9
200-875-0 [3]
649-493-00-X
74-89-5 [1]
649-494-00-5
124-40-3 [2]
649-496-00-6
75-50-3 [3]
649-500-00-6
201-855-4 [1]
649-501-00-1
202-729-1 [2]
649-505-00-3
202-810-1 [3]
649-512-00-1
88-74-4 [1]
649-527-00-3
99-09-2 [2]
649-534-00-1
100-01-6 [3]
Extracts (petroleum), heavy paraffinic distillate solvent, hydrotreated; Distillate aromatic extract (treated);
202-873-5 [1]
649-538-00-3
200-444-7 [2]
649-540-00-4
248-259-0 [3]
650-044-00-5
257-622-2 [4]
Hazard Class and Category Code(s)
100-63-0 [1]
Repr.1B;
59-88-1 [2]
disodium tetraborate, anhydrous; boric acid, disodium salt; [1] tetraboron disodium heptaoxide, hydrate; [2]
27140-08-5 [3]
006-001-00-2
52033-74-6 [4]
006-003-00-3
220-623-3 [1]
006-005-00-4
202-807-5 [2]
006-006-00-X
99-98-9 [2]
4 * STOT RE 2 *
95-55-6
STOT SE 3 Eye Dam.
203-921-8 [1]
2-isopropyloxyphenyl N-methylcarbamate; 2-isopropoxyphenyl methylcarbamate
210-937-9 [2]
(S)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate; [2] esbiothrin;
111-92-2 [1]
249-013-5 [2]-[3]
626-23-3 [2]
006-037-00-9
208-164-7 [1]
006-041-00-0
236-232-6 [2]
3,4-xylyl methylcarbamate; MPMC
237-732-7 [3]
S-ethyl N-(dimethylaminopropyl)thiocarbamatehydrochloride; prothiocarb hydrochloride
513-49-5 [1]
3-chloro-6-cyano-bicyclo(2,2,1)heptan-2-one-O-(N-methylcarbamoyl)oxime; triamid
13250-12-9 [2]
006-069-00-3
13952-84-6 [3]
zineb (ISO); zinc ethylenebis(dithiocarbamate) (polymeric)
210-260-9 [1]
006-086-00-6 fenoxycarb (ISO);
211-795-0 [2]
fosetyl-aluminium (ISO); aluminium triethyl triphosphonate
210-769-6 [3]
520-2
611-21-2 [1]
006-101-00-6 reaction mass of: N, N''-(methylenedi-4,1-phenylene)bis[N'-phenylurea];
696-44-6 [2]
N-(4-[[4-[[(phenylamino)carbonyl]amino]phenylmethyl]phenyl]-N'-cyclohexylurea; N, N''-(methylenedi-4,1-phenylene)bis[N'-cyclohexylurea]
623-08-5 [3]
007-001-01-2
202-805-4 [1]
007-016-00-7
204-495-6 [2]
007-017-00-2
210-199-8 [3]
007-018-00-8
99-97-8 [1]
007-019-00-3
121-72-2 [2]
009-002-00-6
609-72-3 [3]
009-010-00-X
Flam. krut.
009-011-00-5
202-706-6 [1]
alkali fluorosilicates(Na); [1] alkali fluorosilicates(K); [2] alkali fluorosilicates(NH4) [3]
210-545-8 [2]
009-014-00-1
98-84-0 [1]
3 * STOT RE 2 *
618-36-0 [2]
011-007-00-3
823-40-5
reaction mass of: 1,3-dihex-5-en-1-yl-1,1,3,3-tetramethyldisiloxane; 1,3-dihex-n-en-1-yl-1,1,3,3-tetramethyldisiloxane
Nagriz.
reaction mass of: 4-[[bis-(4-fluorophenyl)methylsilyl]methyl]-4H-1,2,4-triazole; 1-[[bis-(4-fluorophenyl)methylsilyl]methyl]-1H-1,2,4-triazole
226-798-2 [1]
015-001-00-1
233-118-8 [2]
015-009-00-5
10039-54-0 [2]
015-019-00-X
123-30-8
015-039-00-9 azinphos-methyl (ISO);
218-255-3 [1]
015-042-00-5
218-256-9 [2]
chlorphonium chloride (ISO); tributyl (2,4-dichlorobenzyl) phosphonium chloride
270-877-4 [3]
015-136-00-6
68479-98-1 [3]
250-366-9 [1]-[2]
108-45-2
reaction mass of: bis(isotridecylammonium)mono(di-(4-methylpent-2-yloxy)thiophosphorothionylisopropyl)phosphate; isotridecylammonium bis(di-(4-methylpent-2-yloxy)thiophosphorothionylisopropyl)phosphate
541-69-5
015-176-00-4
203-403-1 [1]
015-181-00-1
208-740-8 [2]
reaction mass of: potassium o-toluenephosphonate; potassium m-toluenephosphonate; potassium p-toluenephosphonate
208-741-3 [3]
reaction mass of: dimethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate; diethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate; methyl ethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate
106-49-0 [1]
016-017-00-1
540-23-8 [2]
016-063-00-2
540-25-0 [3]
016-064-00-8
130728-76-6
016-077-00-9
65756-41-4
reaction mass of: thiobis(4,1-phenylene)-S, S,S',S'-tetraphenyldisulfonium bishexafluorophosphate; diphenyl(4-phenylthiophenyl)sulfonium hexafluorophosphate; propylene carbonate
69227-51-6
Self-react.
137-17-7 [1]
C ****
210-406-1 [1]
016-092-00-0 reaction mass of: 4,7-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol;
254-323-9 [2]
017-002-01-X
615-05-4 [1]
reaction mass of: dicalcium (bis(2-hydroxy-5-tetra-propenylphenylmethyl)methylamine)dihydroxide; tri-calcium (tris(2-hydroxy-5-tetra-propenylphenylmethyl)methylamine)tri-hydroxide; poly[calcium ((2-hydroxy-5-tetra-propenyl-phenylmethyl)methylamine)hydroxide]
39156-41-7 [2]
023-001-00-8
156-43-4
024-005-00-2
202-765-8 [1]
reaction mass of: tri-sodium [29H, 31H-phthalocyanine-C, C,C-trisulfonato (6-)-N29, N30, N31, N32] manganate (3-); tetrasodium [29H, 31H-phthalocyanine-C, C,C, C-tetrasulfonato(6-)-N29, N30, N31, N32], manganate (3-); pentasodium [29H, 31H-phthalocyanine-C, C,C, C,C-pentasulfonato (6-)-N29, N30, N31, N32] manganate (3-)
256-960-8 [2]
iron (II) sulfate (1:1) heptahydrate; sulfuric acid, iron(II) salt (1:1), heptahydrate; ferrous sulfate heptahydrate
99-55-8 [1]
028-003-00-2
51085-52-0 [2]
028-004-00-8
233-154-4 [1]
028-005-00-3
244-077-0 [2]
028-007-00-4 trinickel disulfide;
242-818-2 [3]
nickel subsulfide; [1] heazlewoodite [2]
258-872-5 [4]
028-008-00-X
10046-00-1 [1]
028-009-00-5
20845-01-6 [2]
028-011-00-6
19098-16-9 [3]
formic acid, nickel salt; [2] formic acid, copper nickel salt [3]
53933-48-5 [4]
nickel difluoride; [1] nickel dibromide; [2] nickel diiodide; [3]
228-042-7 [1]
nickel hydrogen phosphate; [1] nickel bis(dihydrogen phosphate); [2]
205-551-2 [2]
dinickel diphosphate; [4] nickel bis(phosphinate); [5]
217-775-8 [3]
nickel(II) silicate; [1] dinickel orthosilicate; [2] nickel silicate (3:4); [3] silicic acid, nickel salt; [4] trihydrogen hydroxybis[orthosilicato(4-)]trinickelate(3-) [5]
6094-40-2 [1]
258-051-1 [19] 294-302-1 [29] 283-972-0 [30] -[31]
142-64-3 [2]
287-592-6 [28]
1951-97-9 [3]
nickel tellurium trioxide; [2] nickel tellurium tetraoxide; [3] molybdenum nickel hydroxide oxide phosphate [4]
202197-26-0
nickel tungsten tetraoxide; [8] olivine, nickel green; [9]
1239-45-8
029-004-00-0
Asp. toks.
030-003-00-2
Aspir. toks.
zinc sulphate (hydrous) (mono-, hexa-and hepta hydrate); [1] zinc sulphate (anhydrous) [2]
66-81-9
033-004-00-6 diarsenic pentaoxide;
100988-63-4
arsenic pentoxide; arsenic oxide
1484-13-5
GHS06
H319: C ≥ 5 %
GHS08
H360D *** H317 H412
034-002-00-8
613-200-00-3 produkt reakcije bakra,
canola oil acid amide of branched 1,3-propanediamine, N-[3-(tridecyloxy)-propyl]; N, N-diorgano dithiocarbamate molybdenum complex
129630-19-9 [1]
050-001-00-5
129630-17-7 [2]
dibutyltin dichloride; (DBTC)
H361d*** H373**
reaction mass of: bis[(2-ethyl-1-oxohexyl)oxy]dioctyl stannane; bis[((2-ethyl-1-oxohexyl)oxy)dioctylstannyl]oxide; bis(1-phenyl-1,3-decanedionyl)dioctyl stannane; ((2-ethyl-1-oxohexyl)oxy)-(1-phenyl-1,3-decanedionyl)dioctyl stannane
GHS09
H372 (nervous system, immune system) H317
3.2.4023.
H372 (nervous system, immune system) H314
GHS09
051-005-00-X
219-989-7 [1]
053-002-00-9
219-989-7 [2]
056-004-00-8
2592-95-2 [1]
dimercury dichloride; mercurous chloride;
123333-53-9 [2]
phenylmercury nitrate; [1] phenylmercury hydroxide; [2] basic phenylmercury nitrate [3]
418–260–2
080-010-00-X
26157-73-3
2 * STOT RE 2 *
52234-82-9
GHS09
H361d
Repr.
225-432-9 [1]
1A
227-317-9 [2]
STOT RE 2
269-439-5 [3]
butane (containing ≥ 0,1 % butadiene (203-450-8)); [1] isobutane (containing ≥ 0,1 % butadiene (203-450-8)) [2]
269-710-8 [4]
601-008-00-2
4845-99-2 [1]
601-009-00-8
5786-97-0 [2]
200-815-3
68239-26-9 [3]
Flam.
68310-42-9 [4]
2-methylpropene; [3] (Z)-but-2-ene; [4]
GHS07
H373 (hearing organs) H304
202-966-0 [1]
GHS08 Dgr
219-799-4 [2]
(hearing organs) H304
227-534-9 [3]
202-704-5 [1] 203-132-9 [2]
247-714-0 [4]
98-82-8 [1] 103-65-1 [2]
101-68-8 [1]
H372 (hearing organs) H315
5873-54-1 [3]
601-034-00-4
26447-40-5 [4]
1,2-bis[4-fluoro-6-4-sulfo-5-(2-(4-sulfonaphtalene-3-ylazo)-1-hydroxy-3,6-disulfo-8-aminonaphthalene-7-ylazo)phenylamino-1,3,5-triazin-2ylamino]ethane; x-sodium, y-potassium salts x = 7,755 y =0,245
202-039-0 [1]
602-003-00-8
209-544-5 [2]
602-008-00-5
247-722-4 [3]
602-011-00-1
91-08-7 [1]
602-024-00-2
584-84-9 [2]
STOT SE 3 Skin Irrit.
26471-62-5 [3]
polychlorobiphenyls; PCB
241-001-8 [1]
602-045-00-7 DDT (ISO); clofenotane (INN);
239-714-4 [2]
602-058-00-8 α, α-dichlorotoluene;
16938-22-0 [1]
benzylidene chloride; benzal chloride
15646-96-5 [2]
602-067-00-7
615-033-00-1 produkt reakcije difenilmetandiizocijanata,
602-073-00-X
120187-29-3
602-076-00-6
41107-56-6
602-077-00-1
93629-90-4
dodecachloropentacyclo[5.2.1.02,6.03,9.05,8]decane; mirex
Lakt.
Repr.
Org. peroks.
1a
201-091-1 [1]
STOT RE 2 *
219-306-2 [2]
602-096-00-5
220-279-4 [3]
reaction mass of: (R, R)-1,1,1,2,2,3,4,5,5,5-decafluoropentane; (S, S)-1,1,1,2,2,3,4,5,5,5-decafluoropentane
235-527-7 [4]
603-001-00-X
78-18-2 [1]
603-015-00-6
2407-94-5 [2]
603-029-00-2
12262-58-7 [4]
ethylene glycol dimethyl ether; EGDME
7.7.9002.
603-032-00-9
3.7.9004.
603-033-00-4 oxydiethylene dinitrate;
164 oC do –0,5 oC (–263 oF do –31 oF.)]
diethylene glycol dinitrate; digol dinitrate
271-038-5
oxydiethylene dinitrate; diethylene glycol dinitrate;
Muta.
digol dinitrate; [>25 % phlegmatiser]
1B
GHS01
H350 H340 K U
Commission Implementing Regulation (EU) 2018/670
Provedbena uredba Komisije (EU) 2018/670
amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances bromuconazole, buprofezin, haloxyfop-P and napropamide
o izmjeni Provedbene uredbe (EU) br. 540/2011 u pogledu produljenja roka važenja odobrenja aktivnih tvari bromukonazol, buprofezin, haloksifop-P i napropamid
Having regard to Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing of plant protection products on the market and repealing Council Directives 79/117/EEC and 91/414/EEC, and in particular the first paragraph of Article 17 thereof,
uzimajući u obzir Uredbu (EZ) br. 1107/2009 Europskog parlamenta i Vijeća od 21. listopada 2009. o stavljanju na tržište sredstava za zaštitu bilja i stavljanju izvan snage direktiva Vijeća 79/117/EEZ i 91/414/EEZ, a posebno njezin članak 17. prvi stavak,
Part A of the Annex to Commission Implementing Regulation (EU) No 540/2011 sets out the active substances deemed to have been approved under Regulation (EC) No 1107/2009.
U dijelu A Priloga Provedbenoj uredbi Komisije (EU) br. 540/2011 utvrđene su aktivne tvari koje se smatraju odobrenima na temelju Uredbe (EZ) br. 1107/2009.
The approval periods of the substances haloxyfop-P and napropamide will expire on 31 December 2020.
Rok važenja odobrenja aktivnih tvari haloksifop-P i napropamid istječe 31. prosinca 2020.
The approval periods of the substances bromuconazole and buprofezin will expire on 31 January 2021.
Rok važenja odobrenja aktivnih tvari bromukonazol i buprofezin istječe 31. siječnja 2021.
Applications for the renewal of the approval of the active substances included in this Regulation were submitted in accordance with Commission Implementing Regulation (EU) No 844/2012.
Podneseni su zahtjevi za produljenje odobrenja aktivnih tvari obuhvaćenih ovom Uredbom u skladu s Provedbenom uredbom Komisije (EU) br. 844/2012.
It is therefore necessary to extend their approval periods in accordance with Article 17 of Regulation (EC) No 1107/2009.
Stoga je potrebno produljiti rok važenja tih odobrenja u skladu s člankom 17.
In view of the time and resources necessary for completing the assessment of applications for renewal of approvals of large number of active substances the approvals of which are expiring between 2019 and 2021, Commission Implementing Decision C(2016)6104 established a work programme grouping together similar active substances and setting priorities on the basis of safety concerns for human and animal health or the environment as provided for in Article 18 of Regulation (EC) No 1107/2009.
Uredbe (EZ) br. 1107/2009.
As the active substances included in this Regulation do not fall in the prioritised categories of Implementing Decision C(2016)6104, their approval period should be extended by either two or three years, taking into account the current date of expiry, the fact that in accordance with Article 6(3) of Implementing Regulation (EU) No 844/2012 the supplementary dossier for an active substance is to be submitted no later than 30 months before expiry of the approval, the need to ensure a balanced distribution of responsibilities and work among Member States acting as rapporteurs and co-rapporteurs and the available resources necessary for assessment and decision-making.
S obzirom na vrijeme i sredstva koji su potrebni za dovršenje procjene zahtjevâ za produljenje odobrenja velikog broja aktivnih tvari za koje odobrenja istječu između 2019. i 2021., Provedbenom odlukom Komisije C(2016)6104 utvrđen je program rada u kojemu se grupiraju slične aktivne tvari i određuju prioriteti na temelju pitanjâ sigurnosti za zdravlje ljudi i životinja ili za okoliš, kako je predviđeno člankom 18.
It is therefore appropriate to extend the approval period for the active substance buprofezin by two years, and to extend the approval periods of the active substances bromuconazole, haloxyfop-P and napropamide by three years.
Uredbe (EZ) br. 1107/2009.
In view of the aim of the first paragraph of Article 17 of Regulation (EC) No 1107/2009, as regards cases where no supplementary dossier in accordance with Implementing Regulation (EU) No 844/2012 is submitted no later than 30 months before the respective expiry date laid down in the Annex to this Regulation, the Commission will set the expiry date at the same date as before this Regulation or at the earliest date thereafter.
Budući da aktivne tvari iz ove Uredbe nisu obuhvaćene prioritetnim kategorijama u Provedbenoj odluci C(2016)6104, rok važenja odobrenja za te tvari trebalo bi produljiti za dvije ili tri godine, uzimajući u obzir postojeći datum isteka odobrenja, činjenicu da u skladu s člankom 6. stavkom 3.
In view of the aim of the first paragraph of Article 17 of Regulation (EC) No 1107/2009, as regards cases where the Commission will adopt a Regulation providing that the approval of an active substance referred to in the Annex to this Regulation is not renewed because the approval criteria are not satisfied, the Commission will set the expiry date at the same date as before this Regulation or at the date of the entry into force of the Regulation providing that the approval of the active substance is not renewed, whichever date is later.
Provedbene uredbe (EU) br. 844/2012 dopunsku dokumentaciju za aktivnu tvar treba dostaviti najkasnije 30 mjeseci prije isteka odobrenja, potrebu da se osigura ujednačena raspodjela odgovornosti i rada među državama članicama koje djeluju kao izvjestiteljice i suizvjestiteljice te raspoložive resurse potrebne za procjenu i donošenje odluke.
As regards cases where the Commission will adopt a Regulation providing for the renewal of an active substance referred to in the Annex to this Regulation, the Commission will endeavour to set, as appropriate under the circumstances, the earliest possible application date.
Stoga je primjereno produljiti rok važenja odobrenja aktivne tvari buprofezin za dvije godine te rok važenja odobrenja aktivnih tvari bromukonazol, haloksifop-P i napropamid za tri godine.
Implementing Regulation (EU) No 540/2011 should therefore be amended accordingly.
S obzirom na cilj članka 17. prvog stavka Uredbe (EZ) br. 1107/2009, ako se dopunska dokumentacija ne dostavi u skladu s Provedbenom uredbom (EU) br. 844/2012 najkasnije 30 mjeseci prije datuma isteka odobrenja utvrđenog u Prilogu ovoj Uredbi, Komisija će kao datum isteka odobrenja odrediti isti datum koji je vrijedio prije donošenja ove Uredbe ili najraniji mogući datum nakon tog datuma.
The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,
S obzirom na cilj članka 17. prvog stavka Uredbe (EZ) br. 1107/2009, u slučajevima u kojima Komisija donese uredbu kojom se predviđa da se odobrenje aktivne tvari iz Priloga ovoj Uredbi ne produljuje jer nisu ispunjena mjerila za odobrenje, Komisija kao datum isteka određuje isti datum koji je vrijedio prije donošenja ove Uredbe ili datum stupanja na snagu uredbe kojom se predviđa da se odobrenje aktivne tvari ne produljuje, ovisno o tome koji je datum kasniji.
HAS ADOPTED THIS REGULATION:
U slučajevima u kojima Komisija donese uredbu kojom se predviđa produljenje odobrenja aktivne tvari iz Priloga ovoj Uredbi, Komisija će nastojati, u skladu s okolnostima, odrediti najraniji mogući datum primjene.
Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation
Mjere predviđene ovom Uredbom u skladu su s mišljenjem Stalnog odbora za bilje, životinje, hranu i hranu za životinje,
This Regulation shall be binding in its entirety and directly applicable in all Member States.
Dio A Priloga Provedbenoj uredbi (EU) br. 540/2011 mijenja se u skladu s Prilogom ovoj Uredbi.
Done at Brussels, 30 April 2018.
Članak 2.
OJ L 309, 24.11.2009, p. 1.
Sastavljeno u Bruxellesu 30. travnja 2018.
Commission Implementing Regulation (EU) No 540/2011 of 25 May 2011 implementing Regulation (EC) No 1107/2009 of the European Parliament and of the Council as regards the list of approved active substances (OJ L 153, 11.6.2011, p. 1).
Za Komisiju
Commission Implementing Regulation (EU) No 844/2012 of 18 September 2012 setting out the provisions necessary for the implementation of the renewal procedure for active substances, as provided for in Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market (OJ L 252, 19.9.2012, p. 26).
Predsjednik
Commission Implementing Decision of 28 September 2016 on the establishment of a work programme for the assessment of applications for the renewal of approvals of active substances expiring in 2019, 2020 and 2021 in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council (OJ C 357, 29.9.2016, p. 9).
SL L 309, 24.11.2009., str. 1.
ANNEX
Provedbena uredba Komisije (EU) br. 540/2011 od 25. svibnja 2011. o provedbi Uredbe (EZ) br. 1107/2009 Europskog parlamenta i Vijeća u pogledu popisa odobrenih aktivnih tvari (SL L 153, 11.6.2011., str. 1.).
Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows:
Provedbena uredba Komisije (EU) br. 844/2012 od 18. rujna 2012. o određivanju odredaba potrebnih za provedbu postupka obnavljanja odobrenja za aktivne tvari, kako je predviđeno Uredbom (EZ) br. 1107/2009 Europskog parlamenta i Vijeća o stavljanju na tržište sredstava za zaštitu bilja (SL L 252, 19.9.2012., str. 26.).
in the sixth column, expiration of approval, of row 309, Haloxyfop-P, the date is replaced by ‘31 December 2023’;
Provedbena odluka Komisije оd 28. rujna 2016. o uspostavi programa rada za procjenu zahtjeva za produljenje odobrenja aktivnih tvari koja istječu u 2019., 2020. i 2021. u skladu s Uredbom (EZ) br. 1107/2009 Europskog parlamenta i Vijeća (SL C 357, 29.9.2016., str. 9.).
in the sixth column, expiration of approval, of row 310, Napropamide, the date is replaced by ‘31 December 2023’;
PRILOG
in the sixth column, expiration of approval, of row 318, Bromuconazole, the date is replaced by ‘31 January 2024’;
Dio A Priloga Provedbenoj uredbi (EU) br. 540/2011 mijenja se kako slijedi:
in the sixth column, expiration of approval, of row 320, Buprofezin, the date is replaced by ‘31 January 2023’.
u šestom stupcu, prestanak odobrenja, u retku 309., haloksifop-P, datum se zamjenjuje datumom „31. prosinca 2023.”;
Having regard to Regulation (EU) 2016/1036 of the European Parliament and of the Council of 8 June 2016 on protection against dumped imports from countries not members of the European Union (‘the basic anti-dumping Regulation’), and in particular Article 14(5) thereof,
uzimajući u obzir Uredbu (EU) 2016/1036 Europskog parlamenta i Vijeća od 8. lipnja 2016. o zaštiti od dampinškog uvoza iz zemalja koje nisu članice Europske unije („osnovna antidampinška uredba”), a posebno njezin članak 14. stavak 5.,
Having regard to Regulation (EU) 2016/1037 of the European Parliament and of the Council of 8 June 2016 on protection against subsidised imports from countries not members of the European Union (‘the basic anti-subsidy Regulation’), and in particular Article 24(5) thereof,
uzimajući u obzir Uredbu (EU) 2016/1037 Europskog parlamenta i Vijeća od 8. lipnja 2016. o zaštiti od subvencioniranog uvoza iz zemalja koje nisu članice Europske unije („osnovna antisubvencijska uredba”), a posebno njezin članak 24. stavak 5.,